<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pulmo-3442</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTIONS</subject></subj-group></article-categories><title-group><article-title>Клиническая фармакология ингаляционных глюкокортикостероидов</article-title><trans-title-group xml:lang="en"><trans-title>Clinical pharmacology of inhaled glucocorticosteroids</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цой</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsoy</surname><given-names>A. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Московская медицинская академия им. И.М .Сеченова</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>1996</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>1996</year></pub-date><volume>0</volume><issue>2</issue><fpage>85</fpage><lpage>90</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Цой А.Н., 1996</copyright-statement><copyright-year>1996</copyright-year><copyright-holder xml:lang="ru">Цой А.Н.</copyright-holder><copyright-holder xml:lang="en">Tsoy A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/3442">https://journal.pulmonology.ru/pulm/article/view/3442</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Johansson S.A., Andersson К.А., Brattsand R. et al. Topical and systemic glucocorticoid potences of budesonide, beclomethasone dipropionate and prednisolone in man // Eur. Respir. J. — 1982. — Vol. 63, Suppl. 122. — P. 74—82.</mixed-citation><mixed-citation xml:lang="en">Johansson S.A., Andersson К.А., Brattsand R. et al. Topical and systemic glucocorticoid potences of budesonide, beclomethasone dipropionate and prednisolone in man // Eur. Respir. J. — 1982. — Vol. 63, Suppl. 122. — P. 74—82.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes P.J., Pedersen S. Efficacy and Safety of inhaled corticosteroids in asthma // Am. Rev. Respir. Dis. — 1993. — Vol. 148. — P. S1—S26.</mixed-citation><mixed-citation xml:lang="en">Barnes P.J., Pedersen S. Efficacy and Safety of inhaled corticosteroids in asthma // Am. Rev. Respir. Dis. — 1993. — Vol. 148. — P. S1—S26.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wikstrom A.C., Bakke O., Bronnegard М., Gustafsson J.A. Intracellular localisation of the glucocorticoid receptor; evidence for cytoplasmic and nuclear localization // Endocrinology. — 1987. — Vol. 120. — P. 1232—1242.</mixed-citation><mixed-citation xml:lang="en">Wikstrom A.C., Bakke O., Bronnegard М., Gustafsson J.A. Intracellular localisation of the glucocorticoid receptor; evidence for cytoplasmic and nuclear localization // Endocrinology. — 1987. — Vol. 120. — P. 1232—1242.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Londgren J.D., Hirata F. et al. Dexamethasone inhibits respiratory glucoconjugate secretion from airways in vitro by the induction of lipocortin (lipomodulin) synthesis // Am. Rev. Respir. Dis. — 1988. — Vol. 137. — P. 353—357.</mixed-citation><mixed-citation xml:lang="en">Londgren J.D., Hirata F. et al. Dexamethasone inhibits respiratory glucoconjugate secretion from airways in vitro by the induction of lipocortin (lipomodulin) synthesis // Am. Rev. Respir. Dis. — 1988. — Vol. 137. — P. 353—357.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Davidson F.F., D ennis E.A. Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2 // Biochem. Pharmacol. — 1989. — Vol. 38. — P. 3645—3651.</mixed-citation><mixed-citation xml:lang="en">Davidson F.F., D ennis E.A. Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2 // Biochem. Pharmacol. — 1989. — Vol. 38. — P. 3645—3651.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Flower R.J. Lipocortin and the mechanism of action of the glucocorticoids // Br. J. Pharmacol. — 1988. — Vol. 94. — P. 987—1015.</mixed-citation><mixed-citation xml:lang="en">Flower R.J. Lipocortin and the mechanism of action of the glucocorticoids // Br. J. Pharmacol. — 1988. — Vol. 94. — P. 987—1015.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Goudling N.J., Godolphin J.L. et al. Anti-inflammatory lipocortin-1 production by perpheral leucocytes in response to hydrocortisone // Lancet. — 1990. — Vol. 335. — P. 1416—1418.</mixed-citation><mixed-citation xml:lang="en">Goudling N.J., Godolphin J.L. et al. Anti-inflammatory lipocortin-1 production by perpheral leucocytes in response to hydrocortisone // Lancet. — 1990. — Vol. 335. — P. 1416—1418.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mac J.C.W., Adcock I., Barnes P.J. Dexamethasone increases beta-2-adrenoceptor gene expression in human lung (abstract) // Am. Rev. Respir. Dis. — 1992. — Vol. 145. — P. A834.</mixed-citation><mixed-citation xml:lang="en">Mac J.C.W., Adcock I., Barnes P.J. Dexamethasone increases beta-2-adrenoceptor gene expression in human lung (abstract) // Am. Rev. Respir. Dis. — 1992. — Vol. 145. — P. A834.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Laitinen L.A., Laitinen A., Haahtela T.A. A comparative study of effects of an inhaled corticosteroid budesonide and of a ß2-agonists terbutaline on airway inflammation in newly diagnosed asthma // J. Allergy Clin. Immunol. — 1992. — Vol. 90. — P. 32—42.</mixed-citation><mixed-citation xml:lang="en">Laitinen L.A., Laitinen A., Haahtela T.A. A comparative study of effects of an inhaled corticosteroid budesonide and of a ß2-agonists terbutaline on airway inflammation in newly diagnosed asthma // J. Allergy Clin. Immunol. — 1992. — Vol. 90. — P. 32—42.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Boschetto P., Rogers D.F., Fabbri L.M., Barnes P.J. Corticosteroid inhibition of airway microvascular leakage // Am. Rev. Respir. Dis. — 1991. — Vol. 145. — P. 605—609.</mixed-citation><mixed-citation xml:lang="en">Boschetto P., Rogers D.F., Fabbri L.M., Barnes P.J. Corticosteroid inhibition of airway microvascular leakage // Am. Rev. Respir. Dis. — 1991. — Vol. 145. — P. 605—609.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dahlberg E., Thalen A., Brattsand R. et al. Correlation between chemical structure, receptor binding and biological of some novel highly active 16a, 17a-acetate-substituted glucocorticoids // Mol. Pharmacol. — 1984. — Vol. 25. — P. 70—78.</mixed-citation><mixed-citation xml:lang="en">Dahlberg E., Thalen A., Brattsand R. et al. Correlation between chemical structure, receptor binding and biological of some novel highly active 16a, 17a-acetate-substituted glucocorticoids // Mol. Pharmacol. — 1984. — Vol. 25. — P. 70—78.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Phillips G.H. Structure-activity relationship of topically active steroids: the selection of fluticasone propionate // Respir. Med. — 1990. — Vol. 84, Suppl. A. — P. 19—23.</mixed-citation><mixed-citation xml:lang="en">Phillips G.H. Structure-activity relationship of topically active steroids: the selection of fluticasone propionate // Respir. Med. — 1990. — Vol. 84, Suppl. A. — P. 19—23.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Me Kenzie A.W., Stroughton R.B. Method for comparing percutaneus absorbtion of steroids // Arch. Dermatol. — 1962. — Vol. 86. — P. 608—610.</mixed-citation><mixed-citation xml:lang="en">Me Kenzie A.W., Stroughton R.B. Method for comparing percutaneus absorbtion of steroids // Arch. Dermatol. — 1962. — Vol. 86. — P. 608—610.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Baigelman W., Chodosh S., Pzzuto D., Cupples L.A. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma // Am. J. Med. — 1983. — Vol. 75. — P. 929—936.</mixed-citation><mixed-citation xml:lang="en">Baigelman W., Chodosh S., Pzzuto D., Cupples L.A. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma // Am. J. Med. — 1983. — Vol. 75. — P. 929—936.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Evans P.M., OConnor B.J. Fuller R. W., Barnes P.J., Chung K.F. Effect of inhaled corticosteroids of peripherial eosinophil counts and density profiles in asthma // J. Allergy Clin. Immunol. — 1992. — Vol. 91. — P. 643—649.</mixed-citation><mixed-citation xml:lang="en">Evans P.M., OConnor B.J. Fuller R. W., Barnes P.J., Chung K.F. Effect of inhaled corticosteroids of peripherial eosinophil counts and density profiles in asthma // J. Allergy Clin. Immunol. — 1992. — Vol. 91. — P. 643—649.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Martinel N., Vaillant P., Charles I. el al. Dexamethasone modulation of tumor necrosis factor activated normal human alveolar macrophages // Eur. Respir. J. — 1992. — Vol. 5. — P. 67—72.</mixed-citation><mixed-citation xml:lang="en">Martinel N., Vaillant P., Charles I. el al. Dexamethasone modulation of tumor necrosis factor activated normal human alveolar macrophages // Eur. Respir. J. — 1992. — Vol. 5. — P. 67—72.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Van de Graaf E.A., Out T.A., Loos S.M., Jansen H.M. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma // Am. Rev. Respir. Dis. — 1991. — Vol. 143. — P. 362—368.</mixed-citation><mixed-citation xml:lang="en">Van de Graaf E.A., Out T.A., Loos S.M., Jansen H.M. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma // Am. Rev. Respir. Dis. — 1991. — Vol. 143. — P. 362—368.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bel E.N., Timers M.C., Zwinderman A.H. et al. The effect of inhaled corticosterids on the maximal degree of airway narrowing to methacholine // Ibid. — 1991. — Vol. 143. — P. 109—113.</mixed-citation><mixed-citation xml:lang="en">Bel E.N., Timers M.C., Zwinderman A.H. et al. The effect of inhaled corticosterids on the maximal degree of airway narrowing to methacholine // Ibid. — 1991. — Vol. 143. — P. 109—113.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes P.J. Effect of corticosteroids on airway hyperresponsiveness // Ibid. — 1990. — Vol. 141, Suppl. — P. S70—S76.</mixed-citation><mixed-citation xml:lang="en">Barnes P.J. Effect of corticosteroids on airway hyperresponsiveness // Ibid. — 1990. — Vol. 141, Suppl. — P. S70—S76.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Molema J., van Herwaarden C.L.A., Folgering H.T.M. Effect of long-term treatment witn inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma // Eur. Respir. J. — 1989. — Vol. 2. — P. 308—316.</mixed-citation><mixed-citation xml:lang="en">Molema J., van Herwaarden C.L.A., Folgering H.T.M. Effect of long-term treatment witn inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma // Eur. Respir. J. — 1989. — Vol. 2. — P. 308—316.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Groot C.A.A.R., Lamers J.W.J., Molema J. et al. Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsivenes to histamine and distilled water // Ibid. — 1992. — Vol. 5. — P. 1075—1082.</mixed-citation><mixed-citation xml:lang="en">Groot C.A.A.R., Lamers J.W.J., Molema J. et al. Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsivenes to histamine and distilled water // Ibid. — 1992. — Vol. 5. — P. 1075—1082.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes P.J. Antiinflammatory therapy of asthma // Annu Rev. Med. — 1993. — Vol. 44. — P. 229—249.</mixed-citation><mixed-citation xml:lang="en">Barnes P.J. Antiinflammatory therapy of asthma // Annu Rev. Med. — 1993. — Vol. 44. — P. 229—249.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">B ettery P.K., Goldfrey R.W., Adelroth E. et al. Effect of treatment on airway inflammation and thickening of basament membrane reticular collagen in asthma // Am. Rev. Respir. Dis. — 1992. — Vol. 145. — P. 890—899.</mixed-citation><mixed-citation xml:lang="en">B ettery P.K., Goldfrey R.W., Adelroth E. et al. Effect of treatment on airway inflammation and thickening of basament membrane reticular collagen in asthma // Am. Rev. Respir. Dis. — 1992. — Vol. 145. — P. 890—899.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Brithish Thoracic society and others. Guidelines for management of asthma in adults: I-Chronic persistent asthma // Br. Med. J. — 1990. — Vol. 301. — P. 651—653.</mixed-citation><mixed-citation xml:lang="en">Brithish Thoracic society and others. Guidelines for management of asthma in adults: I-Chronic persistent asthma // Br. Med. J. — 1990. — Vol. 301. — P. 651—653.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">International Consensus Report on diagnosis and management of asthma. National Institute of health publication No. 92—3091 // Eur. Respir. J. — 1992. — Vol. 5. — P. 601—641.</mixed-citation><mixed-citation xml:lang="en">International Consensus Report on diagnosis and management of asthma. National Institute of health publication No. 92—3091 // Eur. Respir. J. — 1992. — Vol. 5. — P. 601—641.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Smith M.J., Hodson M.E. High dose beclomethasone inhaler in the treatment of asthma // Lancet. — 1983. — Vol. l. — P. 265—269.</mixed-citation><mixed-citation xml:lang="en">Smith M.J., Hodson M.E. High dose beclomethasone inhaler in the treatment of asthma // Lancet. — 1983. — Vol. l. — P. 265—269.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Toogood J.H. High dose inhaled steroid therapy for asthma // J. Allergy Clin. Immunol. — 1989. — Vol. 83. — P. 528—536.</mixed-citation><mixed-citation xml:lang="en">Toogood J.H. High dose inhaled steroid therapy for asthma // J. Allergy Clin. Immunol. — 1989. — Vol. 83. — P. 528—536.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Svendsen U.G., Frolund L., Heinig J.H. et al. High dose inhaled steroids in the management of asthma: a comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsivenes and adrenal function // Allergy. — 1992. — Vol. 47. — P. 174—180.</mixed-citation><mixed-citation xml:lang="en">Svendsen U.G., Frolund L., Heinig J.H. et al. High dose inhaled steroids in the management of asthma: a comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms, bronchial responsivenes and adrenal function // Allergy. — 1992. — Vol. 47. — P. 174—180.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Salmeron S., Guerin J.C., Godard P. et al. High doses of inhaled corticosterids in instable chronic asthma // Am. Rev. Respir. Dis. — 1989. — Vol. 140. — P. 167—171.</mixed-citation><mixed-citation xml:lang="en">Salmeron S., Guerin J.C., Godard P. et al. High doses of inhaled corticosterids in instable chronic asthma // Am. Rev. Respir. Dis. — 1989. — Vol. 140. — P. 167—171.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Rafferty P., Tucker L.G., Frame M.H. et al. Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assesment of relative prednisolone-sparing effects // Br. J. Dis. Chest. — 1985. — Vol. 79. — P. 244—250.</mixed-citation><mixed-citation xml:lang="en">Rafferty P., Tucker L.G., Frame M.H. et al. Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assesment of relative prednisolone-sparing effects // Br. J. Dis. Chest. — 1985. — Vol. 79. — P. 244—250.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Laursen L.C., Taudort E., Weeke B. High dose inhaled budesonide in treatment of severe steroid-dependent asthma // Eur. J. Respir. Dis. — 1986. — Vol. 68. — P. 19—28.</mixed-citation><mixed-citation xml:lang="en">Laursen L.C., Taudort E., Weeke B. High dose inhaled budesonide in treatment of severe steroid-dependent asthma // Eur. J. Respir. Dis. — 1986. — Vol. 68. — P. 19—28.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Hummel S, Lehtonen L. Comparison of oral steroid-sparing bv high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet 1992;340:1483—7.</mixed-citation><mixed-citation xml:lang="en">Hummel S, Lehtonen L. Comparison of oral steroid-sparing bv high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet 1992;340:1483—7.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ebden P, Jenkins A, Houston G, Davies B.N. Comparison of two high-dose corticosteroid aerosol treatments: beclomethasone dipropionate (1500 mq/day) and budesonide (1600 mq/day)for chronic asthma. Thorax 1986;41:869—74.</mixed-citation><mixed-citation xml:lang="en">Ebden P, Jenkins A, Houston G, Davies B.N. Comparison of two high-dose corticosteroid aerosol treatments: beclomethasone dipropionate (1500 mq/day) and budesonide (1600 mq/day)for chronic asthma. Thorax 1986;41:869—74.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes N.C, Marone G, Di Maria G.U. et all. A comparison o[fluticasone pripionate, 1 mg daly with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. Eur Respir I 1993;6:877-84.</mixed-citation><mixed-citation xml:lang="en">Barnes N.C, Marone G, Di Maria G.U. et all. A comparison o[fluticasone pripionate, 1 mg daly with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. Eur Respir I 1993;6:877-84.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Fabbri L, Burge P.S., Croonenborg L. et all. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993;48:817-23.</mixed-citation><mixed-citation xml:lang="en">Fabbri L, Burge P.S., Croonenborg L. et all. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993;48:817-23.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Smith M.J., Hodson M.E. Effects of long-term inhaled high dose beclomethasone dipropionate on adrenal function // Thorax. - 1983. — Vol. 38. — P. 76—81.</mixed-citation><mixed-citation xml:lang="en">Smith M.J., Hodson M.E. Effects of long-term inhaled high dose beclomethasone dipropionate on adrenal function // Thorax. - 1983. — Vol. 38. — P. 76—81.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Stiksa G., Nemcek K., Glennow C. Adrenal function in asthmatics treated with high-dose budesonide // Respiration. — 1985. - Vol. 48. — P. 91—93.</mixed-citation><mixed-citation xml:lang="en">Stiksa G., Nemcek K., Glennow C. Adrenal function in asthmatics treated with high-dose budesonide // Respiration. — 1985. - Vol. 48. — P. 91—93.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Teelucksingh S., Padfield P.I., Dicker I. et al. A double-blind placebo controlled crossover study of effects upon the hypothalamic- pituitary-adrenal axis of beclomethasone dipropionate metered dose inhaler at 100, 350 and 500 mq four times daily in healthy adults (abstract) // Am. Rev. Respir. Dis. — 1991. - Vol. 143. — P. A626.</mixed-citation><mixed-citation xml:lang="en">Teelucksingh S., Padfield P.I., Dicker I. et al. A double-blind placebo controlled crossover study of effects upon the hypothalamic- pituitary-adrenal axis of beclomethasone dipropionate metered dose inhaler at 100, 350 and 500 mq four times daily in healthy adults (abstract) // Am. Rev. Respir. Dis. — 1991. - Vol. 143. — P. A626.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Andersson P., Ryrfeld A. Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17a, 21 dipropionate in human liver and lung homogenate // J. Pharm. Pharmacol. — 1984. — Vol. 36. — P. 763—765.</mixed-citation><mixed-citation xml:lang="en">Andersson P., Ryrfeld A. Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17a, 21 dipropionate in human liver and lung homogenate // J. Pharm. Pharmacol. — 1984. — Vol. 36. — P. 763—765.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Harding S.M. The human pharmacology of fluticasone dipropionate // Respir. Med. — 1990. — Vol. 84, Suppl. A. — P. 25—29.</mixed-citation><mixed-citation xml:lang="en">Harding S.M. The human pharmacology of fluticasone dipropionate // Respir. Med. — 1990. — Vol. 84, Suppl. A. — P. 25—29.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Mollman H., Rohdewald P., Schmidt E.W. et al. Pharmacokinetics of trimcinolone acetonide and its phosphate ester // Eur. J. Clin Pharmacol. — 1985. — Vol. 29. — P. 85—89.</mixed-citation><mixed-citation xml:lang="en">Mollman H., Rohdewald P., Schmidt E.W. et al. Pharmacokinetics of trimcinolone acetonide and its phosphate ester // Eur. J. Clin Pharmacol. — 1985. — Vol. 29. — P. 85—89.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Ryrfeldt A., Andersson P., Edsbacker S. et al. Pharmacokinetics ans metabolism of budesonide - a selective glucocorticoid // Eur J. Respir. Dis. — 1982. — Vol. 63, Suppl. 122. — P. 86—95.</mixed-citation><mixed-citation xml:lang="en">Ryrfeldt A., Andersson P., Edsbacker S. et al. Pharmacokinetics ans metabolism of budesonide - a selective glucocorticoid // Eur J. Respir. Dis. — 1982. — Vol. 63, Suppl. 122. — P. 86—95.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Pesersson S., Steffensson G., Ekman I. et al. Pharmacokinetics of budesonide in children with asthma // Eur. J. CIin. Pharmacol. - 1987. — Vol. 31. — P. 579—582.</mixed-citation><mixed-citation xml:lang="en">Pesersson S., Steffensson G., Ekman I. et al. Pharmacokinetics of budesonide in children with asthma // Eur. J. CIin. Pharmacol. - 1987. — Vol. 31. — P. 579—582.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Chaplin M.D., Rooks W., Svenson E.W. et al. Flunisolide meta bolism and dinamiks of a metabolite // Clin. Pharmacol. Ther. - 1980. — Vol. 27.— P. 402—413.</mixed-citation><mixed-citation xml:lang="en">Chaplin M.D., Rooks W., Svenson E.W. et al. Flunisolide meta bolism and dinamiks of a metabolite // Clin. Pharmacol. Ther. - 1980. — Vol. 27.— P. 402—413.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Allen M.B., Ray S.G., Dhillon B. et al. Steroid aerosoles anc cataract formatio // Br. Med. J. — 1989. — Vol. 299. — P. 432—433.</mixed-citation><mixed-citation xml:lang="en">Allen M.B., Ray S.G., Dhillon B. et al. Steroid aerosoles anc cataract formatio // Br. Med. J. — 1989. — Vol. 299. — P. 432—433.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Toogood J.H., Crilly R.G., Jones G. et al. Effect of high dose inhaled budesonide on calcium and phosphate metabolism and thf risk of osteoporosis // Am. Rev. Respir. Dis. — 1988. — Vol. 138. - P. 57—61.</mixed-citation><mixed-citation xml:lang="en">Toogood J.H., Crilly R.G., Jones G. et al. Effect of high dose inhaled budesonide on calcium and phosphate metabolism and thf risk of osteoporosis // Am. Rev. Respir. Dis. — 1988. — Vol. 138. - P. 57—61.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Toogood J.H., Jennings B., Greenway R.W., Chung L. Candidi asis and dysphonia complicating beclomethasone treatment o asthma // J. Allergy Clin. Immunol. — 1980. — Vol. 65. - P. 145—153.</mixed-citation><mixed-citation xml:lang="en">Toogood J.H., Jennings B., Greenway R.W., Chung L. Candidi asis and dysphonia complicating beclomethasone treatment o asthma // J. Allergy Clin. Immunol. — 1980. — Vol. 65. - P. 145—153.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Salsman G.A., Mszczynski D.R. Oropharyngeal candidiasis ir patients treated with beclomethasone delivered by metered — dost inhaler alone and with aerochamber // J. Allergy Clin. Immunol. — 1988. — Vol. 81. — P. 424—428.</mixed-citation><mixed-citation xml:lang="en">Salsman G.A., Mszczynski D.R. Oropharyngeal candidiasis ir patients treated with beclomethasone delivered by metered — dost inhaler alone and with aerochamber // J. Allergy Clin. Immunol. — 1988. — Vol. 81. — P. 424—428.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Siewert W., Holmes P., King R.W.F. Oesophageal candidosis it patients on high-dose inhaler steroids // Lancet. — 1992. - Vol. 339. — P. 1551—1552.</mixed-citation><mixed-citation xml:lang="en">Siewert W., Holmes P., King R.W.F. Oesophageal candidosis it patients on high-dose inhaler steroids // Lancet. — 1992. - Vol. 339. — P. 1551—1552.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
